Literature DB >> 18563341

Local Th1/Th2 cytokine expression in experimental murine vaginal candidiasis.

Weixiang Ouyang1, Shanjuan Chen, Zhixiang Liu, Yan Wu, Jiawen Li.   

Abstract

In order to investigate the expression of Th1 and Th2 cytokines in the vaginal candidiasis caused by Candida, the fungal vaginitis model was established in female ICR mice by intravaginal inoculation of suspension of C. albicans after the animals were pretreated with estradiol. Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the expression of IL-2, IL-4, IL-10 and TGF-beta1 in the vagina in the mice of different groups at different time points after the beginning of the experiment. The average expression level of IL-2 mRNA in group D (estrogen-treated mice) was significantly higher than that in groups H (estrogen-untreated mice) and I (control group) on the day 2. The average expression level of IL-4 mRNA in group D was significantly higher than that in groups I and H on the day 5. The average expression level of IL-10 mRNA in group D was significantly higher than that in groups H and I from day 7 to 11. The average expression level of TGF-beta1 mRNA in group D was significantly higher than that in groups H and I at all time points. It was concludes that the high-level expression of IL-2 mRNA during early infection was associated with clearance of mucosal C. albicans, and the high-level expression of IL-10 mRNA during late stage of the infection was related to susceptibility to infection. TGF-beta1 may play a predominant role when the virtual absence of changes in other Th-type cytokines during infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563341     DOI: 10.1007/s11596-008-0329-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta.

Authors:  B N Taylor; M Saavedra; P L Fidel
Journal:  Med Mycol       Date:  2000-12       Impact factor: 4.076

2.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

3.  T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery.

Authors:  P L Fidel; N A Wolf; M A KuKuruga
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  Candidiasis in the transplant patient.

Authors:  R A Clift
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

5.  T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development.

Authors:  E Cenci; A Mencacci; R Spaccapelo; L Tonnetti; P Mosci; K H Enssle; P Puccetti; L Romani; F Bistoni
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

6.  Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.

Authors:  P L Fidel; M E Lynch; D H Conaway; L Tait; J D Sobel
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  The pathology of AIDS.

Authors:  A M Macher
Journal:  Public Health Rep       Date:  1988 May-Jun       Impact factor: 2.792

8.  Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

9.  Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; M E Lynch; V Redondo-Lopez; J D Sobel; R Robinson
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

  9 in total
  3 in total

1.  Lab-Based Retrospective 10-Year Analysis Shows Seasonal Variation of Vaginal Candida Infection Rates in Belgium.

Authors:  Gilbert G G Donders; Kateryna Ruban; Francesca Donders; Reinhilde Reybrouck
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

2.  Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.

Authors:  Xu Zhang; Ting Li; Xi Chen; Suxia Wang; Zhaohui Liu
Journal:  BMC Microbiol       Date:  2018-10-25       Impact factor: 3.605

Review 3.  Recurrent Vulvovaginal Candidiasis: An Immunological Perspective.

Authors:  Diletta Rosati; Mariolina Bruno; Martin Jaeger; Jaap Ten Oever; Mihai G Netea
Journal:  Microorganisms       Date:  2020-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.